Intrinsic Value
Tekla Life Sciences Investors (HQL)
$12.99
+0.19 (+1.48%)
| Enterprise Value | -111.28 |
|---|---|
| Net Debt | -0 |
| Equity Value | -111.28 |
| Shares Outstanding | 26.79 |
| Equity Value Per Share | -4.15 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt